| __timestamp | Supernus Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 116287000 | 11503000 |
| Thursday, January 1, 2015 | 136004000 | 24698000 |
| Friday, January 1, 2016 | 203017000 | 26076000 |
| Sunday, January 1, 2017 | 287023000 | 33570000 |
| Monday, January 1, 2018 | 393541000 | 58697000 |
| Tuesday, January 1, 2019 | 376095000 | 80279000 |
| Wednesday, January 1, 2020 | 467938000 | 84228000 |
| Friday, January 1, 2021 | 504714000 | 106025000 |
| Saturday, January 1, 2022 | 580017000 | 109788000 |
| Sunday, January 1, 2023 | 523742000 | 135576000 |
Unlocking the unknown
In the competitive landscape of biotechnology, understanding financial performance is crucial. This analysis highlights the gross profit trends of Vericel Corporation and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Supernus Pharmaceuticals consistently outperformed Vericel, with an average gross profit nearly six times higher. Notably, Supernus saw a remarkable 400% increase in gross profit, peaking in 2022. Meanwhile, Vericel demonstrated steady growth, achieving a 1,080% increase by 2023. This trend underscores the dynamic nature of the biotech industry, where strategic innovation and market adaptation are key. Investors and stakeholders should consider these trends when evaluating potential growth and stability in the sector. As the industry evolves, these companies' financial trajectories offer valuable insights into their operational efficiencies and market positioning.
Pfizer Inc. and Vericel Corporation: A Detailed Gross Profit Analysis
Sanofi and Vericel Corporation: A Detailed Gross Profit Analysis
Sanofi vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Biogen Inc. vs Vericel Corporation
Incyte Corporation vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Vericel Corporation
Walgreens Boots Alliance, Inc. vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Grifols, S.A. vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Alkermes plc and Supernus Pharmaceuticals, Inc.
MorphoSys AG vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown